カテゴリ： Bizwit Research & Consulting, 世界, 医療/バイオ

移植診断のグローバル市場（2022年-2029年）：分子アッセイ、非分子アッセイ

■ 英語タイトル：Global Transplant Diagnostics Market Size study & Forecast, by Technology (Molecular Assay, Non-molecular Assay), by Product (Reagents & Consumables, Instruments, Software and Services) and Regional Analysis, 2022-2029

調査会社Bizwit Research & Consulting社が発行したリサーチレポート（データ管理コード：BZW23MA109）■ 発行会社/調査会社：Bizwit Research & Consulting
■ 商品コード：BZW23MA109
■ 発行日：2023年4月10日
■ 調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
■ 産業分野：医療
■ ページ数：約200
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用、印刷不可）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Enterprisewide（同一法人内共有可）USD6,250 ⇒換算￥950,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[移植診断のグローバル市場（2022年-2029年）：分子アッセイ、非分子アッセイ]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Bizwit Research社の本調査資料によると、2021年に721.30百万ドルであった世界の移植診断市場規模が、予測期間中（2022年〜2029年）に年平均7.6%で成長すると予想されています。本資料は、移植診断の世界市場にフォーカスし、市場状況や今後の展望についてまとめており、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、技術別（分子アッセイ、非分子アッセイ）分析、製品別（試薬・消耗品、器具、ソフトウェア・サービス）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなどを掲載しています。本書は、主要企業として、Thermo Fisher Scientific, Inc.、Illumina, Inc.、F. Hoffmann La-Roche AG.、Abbott Laboratories, Inc.、Qiagen N.V.、Immucor Transplant Diagnostics, Inc.、Bio-rad Laboratories, Inc.、Affymetrix, Inc.、Omixon Ltd.、Hologic, Inc.、Merck KGaAなどの情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の移植診断市場規模：技術別
- 分子アッセイにおける市場規模
- 非分子アッセイにおける市場規模
・世界の移植診断市場規模：製品別
- 試薬・消耗品の市場規模
- 器具の市場規模
- ソフトウェア・サービスの市場規模
・世界の移植診断市場規模：地域別
- 北米の移植診断市場規模
- ヨーロッパの移植診断市場規模
- アジア太平洋の移植診断市場規模
- 中南米の移植診断市場規模
- その他地域の移植診断市場規模
・競争分析
・調査プロセス

Global Transplant Diagnostics Market is valued approximately USD 721.30 million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.6% over the forecast period 2022-2029. Transplant diagnostics are tests carried out to determine whether the organ recipient and donor are compatible before or after transplant. The major driving factor for the market are increase in the technological advancements in the field of transplants and rising number of transplant procedures. Moreover, strategic initiatives by market players is creating lucrative growth opportunity for the market players over the forecast period 2022-2029.

According to the research conducted at Bizwit Research & Consulting LLP, there is a strong need for liver, kidney, heart, and lung transplants. Organ failure is most commonly caused by alcohol usage, drug addiction, and inactivity. According to the Organ Procurement and Transplantation Network, 41,354 organ transplants were carried out in the United States in 2021, a 5.9 percent increase over the previous year and the first time the yearly total went above 40,000. Organ transplantation also increases patient survival and quality of life, has a significant positive effect on public health, and reduces the socioeconomic burden of organ failure. Europe is a leader in this field because of the European Union’s (EU) generally uniform and systematic approach to organ transplantation, well-established national programmes, global infrastructure to allow organ sharing, and clearly defined exchange policies. However, high cost of organ transplantation is restraining the market growth over the forecast period.

The key regions considered for the Global Transplant Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In terms of revenue share, North America is dominating the market space in 2021. Major influences include the widespread use of cutting-edge methods and diagnostic technologies, rising healthcare costs, and the accessibility of qualified personnel. Due to factors including a highly established healthcare infrastructure and the availability of qualified specialists, the U.S. has the biggest market share. Additionally, the widespread use of stem cell therapies, and soft tissue transplants is promoting regional market expansion. Along with this, Asia Pacific is growing with the fastest CAGR over the forecast period 2022-2029 owing to rising adoption of innovative diagnostic technology, and rising number of organ transplant in the region excelling the growth of the market.

Major market player included in this report are:
Thermo Fisher Scientific, Inc.
Illumina, Inc.
F. Hoffmann La-Roche AG.
Abbott Laboratories, Inc.
Qiagen N.V.
Immucor Transplant Diagnostics, Inc.
Bio-rad Laboratories, Inc.
Affymetrix, Inc.
Omixon Ltd.
Hologic, Inc.
Merck KGaA

Recent Developments in the Market:
 In October 2022, the US-based biotechnology company Plexision, has started conducting business abroad with the opening of a reference laboratory in Hyderabad, India. This facility will provide transplant patients with a wide variety of diagnostics. These tests include drug level monitoring, genetic testing, pharmacogenomics, and the company’s unique tailored transplant diagnostic assays to anticipate viral infections and rejection.
 In March 2022, Immucor, Inc., a leader in transfusion and transplantation diagnostics, recently announced the addition of two new products to its portfolio of transplant diagnostics, illustrating their dedication to new developments in the histocompatibility sector.

Global Transplant Diagnostics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, Product, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
Molecular Assay
Non-molecular Assay

By Product:
Reagents & Consumables
Instruments
Software and Services

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Transplant Diagnostics Market, by Region, 2019-2029 (USD Million)
1.2.2. Transplant Diagnostics Market, by Technology, 2019-2029 (USD Million)
1.2.3. Transplant Diagnostics Market, by Product, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Transplant Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Transplant Diagnostics Market Dynamics
3.1. Transplant Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increase in the technological advancements in the field of transplants
3.1.1.2. Rising number of transplant procedures
3.1.2. Market Challenges
3.1.2.1. High Cost of organ transplantation
3.1.3. Market Opportunities
3.1.3.1. Strategic initiatives by the key market players
Chapter 4. Global Transplant Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Transplant Diagnostics Market, by Technology
6.1. Market Snapshot
6.2. Global Transplant Diagnostics Market by Technology, Performance – Potential Analysis
6.3. Global Transplant Diagnostics Market Estimates & Forecasts by Technology 2019-2029 (USD Million)
6.4. Transplant Diagnostics Market, Sub Segment Analysis
6.4.1. Molecular Assay
6.4.2. Non-molecular Assay
Chapter 7. Global Transplant Diagnostics Market, by Product
7.1. Market Snapshot
7.2. Global Transplant Diagnostics Market by Product, Performance – Potential Analysis
7.3. Global Transplant Diagnostics Market Estimates & Forecasts by Product 2019-2029 (USD Million)
7.4. Transplant Diagnostics Market, Sub Segment Analysis
7.4.1. Reagents & Consumables
7.4.2. Instruments
7.4.3. Software and Services
Chapter 8. Global Transplant Diagnostics Market, Regional Analysis
8.1. Transplant Diagnostics Market, Regional Market Snapshot
8.2. North America Transplant Diagnostics Market
8.2.1. U.S. Transplant Diagnostics Market
8.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
8.2.1.2. Product breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Transplant Diagnostics Market
8.3. Europe Transplant Diagnostics Market Snapshot
8.3.1. U.K. Transplant Diagnostics Market
8.3.2. Germany Transplant Diagnostics Market
8.3.3. France Transplant Diagnostics Market
8.3.4. Spain Transplant Diagnostics Market
8.3.5. Italy Transplant Diagnostics Market
8.3.6. Rest of Europe Transplant Diagnostics Market
8.4. Asia-Pacific Transplant Diagnostics Market Snapshot
8.4.1. China Transplant Diagnostics Market
8.4.2. India Transplant Diagnostics Market
8.4.3. Japan Transplant Diagnostics Market
8.4.4. Australia Transplant Diagnostics Market
8.4.5. South Korea Transplant Diagnostics Market
8.4.6. Rest of Asia Pacific Transplant Diagnostics Market
8.5. Latin America Transplant Diagnostics Market Snapshot
8.5.1. Brazil Transplant Diagnostics Market
8.5.2. Mexico Transplant Diagnostics Market
8.5.3. Rest of Latin America Transplant Diagnostics Market
8.6. Rest of The World Transplant Diagnostics Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Thermo Fisher Scientific, Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Illumina, Inc.
9.2.3. F. Hoffmann La-Roche AG.
9.2.4. Abbott Laboratories, Inc.
9.2.5. Qiagen N.V.
9.2.6. Immucor Transplant Diagnostics, Inc.
9.2.7. Bio-rad Laboratories, Inc.
9.2.8. Affymetrix, Inc.
9.2.9. Omixon Ltd.
9.2.10. Hologic, Inc.
9.2.11. Merck KGaA
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Transplant Diagnostics Market, report scope
TABLE 2. Global Transplant Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global Transplant Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Million)
TABLE 4. Global Transplant Diagnostics Market estimates & forecasts by Product 2019-2029 (USD Million)
TABLE 5. Global Transplant Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 6. Global Transplant Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 7. Global Transplant Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global Transplant Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global Transplant Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global Transplant Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global Transplant Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global Transplant Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global Transplant Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global Transplant Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. U.S. Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. U.S. Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 17. U.S. Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 18. Canada Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 19. Canada Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 20. Canada Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 21. UK Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 22. UK Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 23. UK Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 24. Germany Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 25. Germany Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 26. Germany Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 27. France Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 28. France Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 29. France Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 30. Italy Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 31. Italy Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 32. Italy Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 33. Spain Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 34. Spain Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 35. Spain Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 36. RoE Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 37. RoE Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 38. RoE Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 39. China Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 40. China Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 41. China Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 42. India Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 43. India Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 44. India Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 45. Japan Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 46. Japan Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 47. Japan Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 48. South Korea Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 49. South Korea Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 50. South Korea Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 51. Australia Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 52. Australia Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 53. Australia Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 54. RoAPAC Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 55. RoAPAC Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 56. RoAPAC Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 57. Brazil Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 58. Brazil Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 59. Brazil Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 60. Mexico Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 61. Mexico Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 62. Mexico Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 63. RoLA Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 64. RoLA Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 65. RoLA Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 66. Row Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 67. Row Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 68. Row Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 69. List of secondary sources, used in the study of global Transplant Diagnostics Market
TABLE 70. List of primary sources, used in the study of global Transplant Diagnostics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の移植診断市場（～2030年）：技術別（分子アッセイ、非分子アッセイ）、提供品目別（試薬・消耗品、機器、ソフトウェア、サービス）、移植タイプ別（固形臓器、幹細胞、軟組織、骨髄）、用途別（診断、研究）、エンドユーザー別（病院・移植センター、研究・学術機関、独立系リファレンスラボ）
  • 移植診断のグローバル市場：機器＆装置、試薬＆消耗品、ソフトウェア＆サービス
  • 人工角膜インプラントのグローバル市場（2022年-2029年）：ハード人工角膜移植術、ソフト人工角膜移植術
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(BZW23MA109 )"移植診断のグローバル市場（2022年-2029年）：分子アッセイ、非分子アッセイ" (英文：Global Transplant Diagnostics Market Size study & Forecast, by Technology (Molecular Assay, Non-molecular Assay), by Product (Reagents & Consumables, Instruments, Software and Services) and Regional Analysis, 2022-2029)はBizwit Research & Consulting社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。